Notice of Modifications of PA-18-842 "Administrative Supplements to Support Cancer Disparity Collaborative Research"

Notice Number: NOT-CA-20-006

Key Dates
Release Date: November 20, 2019

Related Announcements
PA-18-842

Issued by
National Cancer Institute (NCI)

Purpose

The purpose of this Notice is to modify PA-18-842, “Administrative Supplements to Support Cancer Disparity Collaborative Research)," by adding five additional activity codes (R00, R21, R21/R33, UH2/UH3, and UG3/UH3) as awards eligible for the specified administrative supplements and by adding an additional (i.e., a new penultimate) application due date, together with the associated open and start dates.

In Part 1. Overview Information, under Activity Code, five additional activity codes (i.e., R00, R21, R21/R33, UG3/UH3, and UH2/UH3) have been added.

Activity Code

Administrative Supplement

Additional funds may be awarded as supplements to parent awards using the following Activity Code(s):

Administrative supplement requests must be submitted on paper for the following activity codes:

P01 Research Program Projects
P20 Exploratory Grants
P50 Specialized Center

U19 Research Program - Cooperative Agreements
U54 Specialized Center - Cooperative Agreements
UM2 Program Project or Center with Complex Structure Cooperative Agreement

Administrative supplement requests may be submitted electronically for the following activity codes:

R00 (R00 portion only of K99/R00) Research Transition Award

R01 Research Project Grant

R21 Exploratory/Developmental Grants

R21/R33 Exploratory/Developmental Grants Phase I/Phase II
R37 Method to Extend Research in Time (MERIT) Award
U01 Research Project Cooperative Agreements

UG1 Clinical Research Cooperative Agreements - Single Project

UG3/UH3 Exploratory/Developmental Cooperative Agreement Phase I/Phase II

UH2/UH3 Exploratory/Developmental Cooperative Agreement Phase I/Phase II

UM1 Multi-Component Research Project Cooperative Agreements

In Part 1. Overview Information, under Key Dates, one additional series of sequentially linked open, application due, and start dates have been added.

Open Date(s)

August 10, 2018; August 10, 2019; January 10, 2020; August 10, 2020

Application Due Date(s)

September 10, 2018, September 10, 2019, February 10, 2020; September 10, 2020, by 5:00 PM local time of applicant organization.

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

Scientific Merit Review

Not Applicable

Advisory Council Review

Not Applicable

Earliest Start Date

October 2018; October 2019; March 2020; October 2020

Inquiries

Please direct all inquiries to:

Elizabeth Perruccio, Ph.D.
National Cancer Institute
Telephone: 240-276-6178
Email: [email protected]